David Shulkin sets out very clearly that this week’s proposed deal means additional funding will be approved for the VA. Even winning a small piece of the “mandatory” PACT Act expenditure of USD 20.3 billion pie in FY2024 (a USD 15.3 billion increase) on toxic exposures would be company changing for 4DX - yet just a drop in the ocean for the VA. Let’s go team!
Research, page-1576
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.5¢ |
Change
0.005(0.94%) |
Mkt cap ! $219.6M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 53.5¢ | 51.5¢ | $87.23K | 165.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1972 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.5¢ | 18244 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |